Angiotensin-converting enzyme gene polymorphism and geometric patterns of hypertensive left ventricular hypertrophy

Japanese Heart Journal

Volumn 40, Issue 5, 1999, Pages 589-598

  Ueno, Hitoshi ^a   Takata, Masanobu ^a   Yasumoto, Kotaro ^a   Tomita, Shin ^a   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

ACE gene polymorphism; Essential hypertension; Left ventricular hypertrophy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GENOTYPE; GEOMETRY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THICKNESS;

EID: 0032777261     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.40.589     Document Type: Article

References (36)

1. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-52.
2. Levy D. Left ventricular hypertrophy: epidemiological insights from the Framingham Heart study. The Framingham study, 36 year follow-up. Drugs 1988; 35 (Suppl 5): 1-5.
3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study. N EnglJ Med 1990; 322: 1561-66.
4. Ueno H, Takata M, Tomita S, Oh-hashi S, Yasumoto K, Inoue H. The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relationship to changes in neurohumoral factors. J Cardiovasc Pharmacol 1997; 30: 643-8.
5. Ganau A, Devereux RB, Pickering TG, et al. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 1990; 81: 25-36.
6. Leenen FH, Tsoporis J. Cardiac volume load as a determinant of the response of cardiac mass to antihypertensive therapy. Eur Heart J 1990; 11 (suppl G): s 100-6.
7. Roman MJ, Saba PS, Pini R, et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909-18.
8. Corea L, Bentivoglo M, Verdecchia P, Motolese M. Left ventricular wall thickness and plasma cathecholamines in borderline and stable essential hypertension. Eur Heart J 1982; 3: 164-70.
9. Geenen DL, Malhotra A, Scheuer J. Angiotensin II increases cardiac protein synthesis in adult rat heart. AmJ Physiol 1993; 265: H238-43.
10. Susic D, Nunez E, Frohlich ED, Prakash O. Angiotensin II increases left ventricular mass affecting myosin isoform mRNAs. Hypertension 1996; 28: 265-8.
11. Schmieder RE, Messerli FH, Garavaglia GE, Nunez B, MacPhee AA, Re RN. Does the reninangiotensin-aldosterone system modify cardiac structure and function in essential hypertension? Am J Med 1988; 84 (suppl 3A): 136A-9A.
12. Cornoni-Huntley J, Lacroix AZ, Hanlik RJ. Race and sex differentials in the impact of hypertension in the United States: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 1989; 149: 780-8.
13. Sasson Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993; 88: 1431-6.
14. Levy D, Anderson KM, Savage DD, Kannl WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: The Framingham Heart Study. Ann Intern Med 1988; 108: 7-13.
15. Erdös EG, Skidgel RA. The angiotensin I-converting enzyme. Lab Invest 1987; 56: 345-8.
16. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
17. Ueda S, Elliott HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995; 25: 1266-9.
18. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
19. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2622-8.
20. Samani NJ, Martin DS, Brack M, et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet 1995; 345: 1013-6.
21. Castellano M, Muiesan ML, Rizzoni D, et al. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation 1995; 91: 2721-4.
22. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-8.
23. Wong KK, Summers KM, Burstow DJ, West MJ. Angiotensin-converting enzyme and angiotensinogen genes in patterns of left ventricular hypertrophy and in diastolic dysfunction. Clin Exp Pharmacol Physiol 1995; 22: 438-40.
24. Gharavi AG, Lipkowitz MS, Diamond JA, Jhang JS, Phillips RA. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol 1996; 77: 1315-9.
25. World Health Organization: Arterial Hypertension: Report of a WHO Expert Committee. WHO Technical Report Series, 628. Geneva: World Health Organization; 1978.
26. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-8.
27. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC. ACE gene typing. Lancet 1994; 343: 851.
28. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCPl) (dipeptidyl carboxypeptidase 1). Nucl Acid Res 1992; 20: 1433.
29. Haber E, Koerner T, Page LB, Kliman B, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 1969; 29: 1349-55.
30. Ogihara T, Iinuma K, Nishi K, Arakawa Y, Takagi A. A non-chromatographic non-extraction radio-immunoassay for serum aldosterone. J Clin Endocrinol Metab 1977; 45: 726-31.
31. Hosoi M, Nishizawa Y, Kogawa K, et al. Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin dependent diabetic patients. Circulation 1996; 94: 704-7.
32. Lauchurie ML, Azizi M, Guyene TT, Alhene-Gelas F, Menard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995; 91: 2933-42.
33. Schunkert H, Hense HW, Holmer SR. et al. Association between a deletion polymorphism of the angiotensin converting-enzyme gene and left ventricular hypertrophy. New Engl J Med 1994; 330: 1634-8.
34. Perticone F, Ceravolo R, Cosco C. et at. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. J Am Coll Cardiol 1997; 29: 365-9.
35. Lindpaintner K, Lee M, Larson MG, et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. New Engl J Med 1996; 334: 1023-8.
36. Kupari M, Perola M, Koskinen P, et al. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994; 267: H1107-11.